Showing results (171-180 of 334) with videos related to

Sort By:
Pageof 34
Veterinary Microbiology|July 1, 1990
Characterisation of Chlamydia psittaci isolated from a horseJ M Wills, G Watson, M Lusher, et al.
Cancer Letters|July 30, 2005
Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymomaDavid W Hamilton, Meryl E Lusher, Janet C Lindsey, et al.
JAMA|June 16, 1989
The use of purified clotting factor concentrates in hemophilia. Influence of viral safety, cost, and supply on therapyG F Pierce, J M Lusher, A P Brownstein, et al.
Drug Discovery Today|December 24, 2013
Data-driven medicinal chemistry in the era of big dataScott J Lusher, Ross McGuire, René C van Schaik, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 26, 2000
Safety and immunogenicity of subcutaneous hepatitis A vaccine in children with haemophiliaM V Ragni, J M Lusher, M A Koerper, et al.
British Journal of Haematology|May 22, 2008
Thromboelastography in children with coagulation factor deficienciesMeera Chitlur, Indira Warrier, Madhvi Rajpurkar, et al.
Applied Spectroscopy|May 13, 2020
Is It or Isn't It: The Importance of Visual Classification in Microplastic CharacterizationAmy L Lusher, Inger Lise N Bråte, Keenan Munno, et al.
Thrombosis Research|August 2, 2006
Pulmonary embolism-experience at a single children's hospitalMadhvi Rajpurkar, Indira Warrier, Meera Chitlur, et al.
Neuro-Oncology|September 2, 2011
RASSF1A and the BH3-only mimetic ABT-737 promote apoptosis in pediatric medulloblastoma cell linesJane Levesley, Meryl E Lusher, Janet C Lindsey, et al.
Pediatric Blood & Cancer|May 22, 2008
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopeniaZhihong J Wang, Nkechi Onwuzurike, Michael U Callaghan, et al.
Pageof 34